Clinical Trials
3 trialsNCT01644968 2022-05-17
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Providence Health & Services
Phase 1 Completed
NCT01611298 2020-04-21
TAR
Baylor College of Medicine
Phase NA Completed
NCT00369291 2017-11-29
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated